These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29300382)

  • 21. CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.
    Rodriguez JL; Thomas CC; Massetti GM; Duquette D; Avner L; Iskander J; Khoury MJ; Richardson LC
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(46):1291-1294. PubMed ID: 27880748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary Colorectal Cancer.
    Hampel H; Kalady MF; Pearlman R; Stanich PP
    Hematol Oncol Clin North Am; 2022 Jun; 36(3):429-447. PubMed ID: 35577708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of a Population-Based Cancer Family History Screening Program for Lynch Syndrome.
    Lahiri S; Pirzadeh-Miller S; Moriarty K; Kubiliun N
    Cancer Control; 2023; 30():10732748231175011. PubMed ID: 37161761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lynch Syndrome: A Single Hereditary Cancer Syndrome or Multiple Syndromes Defined by Different Mismatch Repair Genes?
    Valle L
    Gastroenterology; 2023 Jul; 165(1):20-23. PubMed ID: 37142200
    [No Abstract]   [Full Text] [Related]  

  • 25. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
    Mester JL; Moore RA; Eng C
    Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Lynch Syndrome and Associated Endometrial Cancer.
    Tafe LJ
    J Mol Diagn; 2015 Sep; 17(5):472-82. PubMed ID: 26162329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes.
    Rich TA; Liu M; Etzel CJ; Bannon SA; Mork ME; Ready K; Saraiya DS; Grubbs EG; Perrier ND; Lu KH; Arun BK; Woodard TL; Schover LR; Litton JK
    Fam Cancer; 2014 Jun; 13(2):291-9. PubMed ID: 24072553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When and how to perform genetic testing for inherited colorectal cancer syndromes.
    Lynch PM
    J Natl Compr Canc Netw; 2013 Dec; 11(12):1577-83. PubMed ID: 24335689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary cancer syndromes: implications for practice.
    Yeomans AC
    Dimens Oncol Nurs; 1990; 4(3):17-26. PubMed ID: 1964054
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.
    Stratton KL; Alanee S; Glogowski EA; Schrader KA; Rau-Murthy R; Klein R; Russo P; Coleman J; Offit K
    Urol Oncol; 2016 May; 34(5):238.e1-7. PubMed ID: 26723226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical management of hereditary colorectal cancer syndromes.
    Vasen HF; Tomlinson I; Castells A
    Nat Rev Gastroenterol Hepatol; 2015 Feb; 12(2):88-97. PubMed ID: 25582351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary cancer syndromes, their testing and prevention.
    Foretová L
    Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SEOM clinical guidelines for hereditary cancer.
    Graña B; Lastra E; Llort G; Brunet J; Isla D
    Clin Transl Oncol; 2011 Aug; 13(8):580-6. PubMed ID: 21821494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of the PRED-IdF, a regional network dedicated to patients with hereditary predisposition to digestive cancers].
    Perrod G; Samaha E; Bats AS; Cellier C
    Ann Pathol; 2020 Apr; 40(2):114-119. PubMed ID: 32199653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetically engineered mouse models for hereditary cancer syndromes.
    Biswas K; Mohammed A; Sharan SK; Shoemaker RH
    Cancer Sci; 2023 May; 114(5):1800-1815. PubMed ID: 36715493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the potential of state-based public health genomics programs to mitigate disparities in access to clinical genetic services.
    Senier L; Tan C; Smollin L; Lee R
    Genet Med; 2019 Feb; 21(2):373-381. PubMed ID: 29895854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary Cancer Syndrome Carriers: Feeling Left in the Corner.
    Diez de Los Rios de la Serna C; Lluch-Canut MT; Fernández-Ortega MP
    Semin Oncol Nurs; 2024 Jun; 40(3):151624. PubMed ID: 38575458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
    Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
    Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.